Tom_Riffel Profile Banner
Tom Riffelmacher Profile
Tom Riffelmacher

@Tom_Riffel

Followers
299
Following
641
Media
33
Statuses
290

Professor; University of Cologne; We research Immunometabolism, unconventional T cells, and cardio-oncology.

San Diego, CA
Joined July 2014
Don't wanna be here? Send us removal request.
@KBoettcherLab
Katrin Böttcher
2 months
Thank you @EKFStiftung for highlighting our recent publication on how MASLD-associated PUFAS impair MAIT cell anti-tumour function as paper of the month 🙏🏻🤩
@EKFStiftung
Else Kröner-Fresenius-Stiftung
2 months
Katrin Böttcher und ihr Team haben einen Mechanismus entdeckt, der erklärt, warum Erkrankte mit metabolisch-assoziierter steatotischer Lebererkrankung (MASLD) besonders gefährdet sind, an Leberkrebs zu erkranken. 💡 @KBoettcherLab 👉 https://t.co/mSuzFIC5OP
0
3
9
@LabWaggoner
Waggoner Lab
2 months
Review @NatRevImmunol @Tom_Riffel @MkronenbergLJI 🇺🇸🇩🇪 Metabolic control of innate-like T cells https://t.co/BOhHwbFP91
0
1
5
@Tom_Riffel
Tom Riffelmacher
2 months
https://t.co/ehuTx1Av6i Just in time for #Cd1Mr12025 Our Review on Innate-like T cell Metabolism is out! Access free here: https://t.co/ondsf6mIAJ Please share with your Immunometabolism friends! @MAITcells @ljiresearch @UniCologne @NaturePortfolio @NatRevImmunol
0
0
6
@Tom_Riffel
Tom Riffelmacher
2 months
reminder to self:
0
0
5
@MatthiasNahrend
Matthias Nahrendorf
2 months
New concept & changes to peer review to make it faster and more friendly: 👇 Unleashing the Power of the Beehive to Begin a New Era for JACC: Basic to Translational Science https://t.co/Mo1MgT0S3M This only works if you, our readers, authors and referees, embrace it!!
Tweet card summary image
jacc.org
2
12
31
@Tom_Riffel
Tom Riffelmacher
3 months
Eine MTA/BTA Stelle - noch offen bei uns im Lab! Join us!
0
1
1
@Tobias_B_Huber
Tobias B. Huber
3 months
Congrats to @KonstantinKltz & team @KSusztak! We loved seeing this work as a late-breaking highlight at the @ISGDtweets #IPC2025 in Hamburg just two months ago. @HCKH_Hamburg
@KSusztak
Katalin Susztak
3 months
🚨 Big news from @SusztakLab! Our paper is out in @NatureGenet: "From Million-Cell Atlases to One-Patient Reports" 🧬🧑‍⚕️Together with biostats wizard @NancyRZhang and physician-scientist trainee @KonstantinKltz, we built a cross-species single-cell kidney atlas and analytics
1
4
17
@AdrianoAguzzi
Adriano Aguzzi
3 months
My whole lab thinks that the last paragraph of a paper's Introduction should report the Results of the study. I don't push back but I disagree. Results are concisely reported in Abstract, then extensively in Results, and then again in Discussion. It's enough!
33
15
348
@Immunometaboli2
Immunometabolism
4 months
Welcome to read the comments from Professor Christian Frezza @FrezzaLab and his colleague on this paper. "Macrophage respiratory complex III governs immune evasion" https://t.co/8PeK36eNik
@ZottaAlessia
Alessia Zotta
10 months
Thrilled to share the work of my PhD,out in @ScienceAdvances!🥳We discovered that complex III regulates IL-10 production in macrophages and its targeting decreases tumor growth in mice🧫Grazie a Luke,LON Lab & collaborators🔬 #immunometabolism #lover👇
0
6
17
@HelmholtzMunich
Helmholtz Munich | @HelmholtzMunich
4 months
Lichtenberg Medal for Matthias Tschöp: Pioneering Research in Metabolic Medicine 👏 👉 https://t.co/i1kNwGsfRI The Göttingen Academy of Sciences and Humanities in Lower Saxony honors Prof. Matthias Tschöp, CEO and Scientific Director at #HelmholtzMunich and Alexander von
0
2
14
@Tobias_B_Huber
Tobias B. Huber
5 months
Hamburg News: Study by the Krebs/ Panzer/ Asada team reveals that IFN-I induces cytotoxic ISG-T cells in lupus and AAV glomerulonephritis - uncovering a critical IFN-I–T cell axis in autoimmune kidney injury. @HCKH_Hamburg @UKEHamburg @krebs_lab https://t.co/uGa2SI5wN7
Tweet card summary image
nature.com
Nature Communications - Glomerulonephritis is a frequent complication of autoimmune diseases, and involves aberrant activation of immune cells, but the underlying insights remain unclear. Here the...
1
3
27
@KBoettcherLab
Katrin Böttcher
5 months
I am more than happy that our study on MAIT cells in MASLD and their role in liver cancer immunity is now out in Journal of Hepatology!! 🤩 ⬇️ Here's a thread about: 🧬 Immunometabolic dysfunction of MAIT cells in MASLD: A novel barrier to liver cancer immunity 🧬
2
4
10
@Tom_Riffel
Tom Riffelmacher
5 months
! ! We are hiring ! ! We offer a postdoc position for someone excited about #immunology and #metabolism! Please share with your colleagues and anyone you know that might be interested! https://t.co/uqVm16UOWD
Tweet card summary image
jobs-uk-koeln.onlyfy.jobs
This job is not active anymore. It was closed on Sep 5, 2025.
2
12
29
@ImmunologyAU
Immunology Center of Georgia at Augusta University
5 months
Foamy macrophages aren’t just bystanders in atherosclerosis. They may hold the key to controlling inflammation. Check out this new review from @MarcoOrecchioni & team @FrontiersIn:
Tweet card summary image
frontiersin.org
Atherosclerosis is a complex immuno-metabolic disease characterized by lipid accumulation and chronic inflammation within arterial walls, leading to cardiova...
0
3
11
@gabrieleschiat1
Gabriele G. Schiattarella
6 months
🚨 Out now in Circulation Research 🚨 So proud with @mkontari to launch this Compendium on Interorgan Crosstalk in Heart Failure & Cardiometabolic Disease. Heart failure it’s systemic. Multiorgan. Dynamic. @CircRes @dzhk_germany @dhzcharite @MDC_Berlin
@CircRes
Circulation Research
6 months
@CircRes May 23rd Issue is Out! Compendium on Interorgan Crosstalk in Heart Failure and Cardiometabolic Diseases In this issue read 14 reviews & 5 Research Letters: https://t.co/STHYRFUtry @gabrieleschiat1 @mkontari
2
12
47
@Tom_Riffel
Tom Riffelmacher
6 months
Today, a dream came true! I am starting my lab as Professor in the dept of medicine III at @UniCologne We will explore the immunometabolic control of unconventional lymphocytes in cancer and cardiovascular disease. WE ARE HIRING AT ALL LEVELS (MTA/BTA, postdoc, PHD)
8
1
23
@Tom_Riffel
Tom Riffelmacher
6 months
Great time catching up with friends from near and far, and making new ones at HawAAI #AAI2025 #IMMUNOLOGY2025
0
0
9
@Tom_Riffel
Tom Riffelmacher
6 months
„Choose europe for science“ - nice initiative
@ERC_Research
European Research Council (ERC)
6 months
The ERC welcomes the offer of substantial additional budget from the @EU_Commission for the development of a new ERC funding instrument offering larger, longer-term grants, as announced by President @vonderleyen at the Sorbonne this morning. https://t.co/SafqcNA58u
0
0
2
@Tom_Riffel
Tom Riffelmacher
6 months
HawAAI 2025 in full swing. DM me if you are here and want to catch up or get to know each other! #AAI2025 #Immunology2025 #MAIT #immunometabolism
0
0
0